These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2847458)

  • 61. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 62. Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.
    Höök M; Björk I; Hopwood J; Lindahl U
    FEBS Lett; 1976 Jul; 66(1):90-3. PubMed ID: 1278445
    [No Abstract]   [Full Text] [Related]  

  • 63. Interaction of heparin with antithrombin III and platelet factor 4: pH dependence demonstrated with a new rocket precipitin Electrophoretic procedure.
    Wohl H; Hinkley J; Krishnan L; Weekly L
    Anal Biochem; 1982 Sep; 125(2):433-41. PubMed ID: 7181101
    [No Abstract]   [Full Text] [Related]  

  • 64. Identification of the cleavage sites resulting from enzymatic inactivation of human antithrombin III by Crotalus adamanteus proteinase II in the the presence and absence of heparin.
    Kress LF; Catanese JJ
    Biochemistry; 1981 Dec; 20(26):7432-8. PubMed ID: 7034776
    [No Abstract]   [Full Text] [Related]  

  • 65. The molecular mechanisms of heparin action: II. Separation of functionally different heparins by affinity chromatography.
    Walker FJ; Esmon CT
    Thromb Res; 1979 Jan; 14(1):219-30. PubMed ID: 570741
    [No Abstract]   [Full Text] [Related]  

  • 66. Heparin - plasmaprotein interactions. Current status.
    Steinbuch M
    Rev Fr Transfus Immunohematol; 1982 Apr; 25(2):217-38. PubMed ID: 7048490
    [No Abstract]   [Full Text] [Related]  

  • 67. Kinetic analysis of the clotting system in the presence of heparin and depolymerized heparin.
    Heuck CC; Baumann P
    Haemostasis; 1991; 21(1):10-8. PubMed ID: 1650744
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Kinetics of binding of I-125-labeled heparin and its low-molecular-weight fraction CY 222 to the endothelium in vitro].
    Psuja P
    Acta Haematol Pol; 1987; 18(1-2):35-41. PubMed ID: 2829494
    [No Abstract]   [Full Text] [Related]  

  • 69. [Antithrombin III during coagulation in vitro].
    Aiach M; Andreux JP; Fiessinger JN; Beuvin J; Leclerc M
    Ann Pharm Fr; 1976; 34(1-2):43-50. PubMed ID: 970875
    [No Abstract]   [Full Text] [Related]  

  • 70. Heterogeneity of heparin.
    Walton PL; Ricketts CR; Bangham DR
    Br J Haematol; 1966 May; 12(3):310-25. PubMed ID: 5935988
    [No Abstract]   [Full Text] [Related]  

  • 71. [Heparin and its low molecular weight derivatives].
    Aiach M
    Rev Prat; 1989 Oct; 39(22):1973-7. PubMed ID: 2554484
    [No Abstract]   [Full Text] [Related]  

  • 72. Pharmacokinetics of heparin and of dermatan sulfate: clinical implications.
    Boneu B; Caranobe C; Salvin S; Dol F; Sié P
    Adv Exp Med Biol; 1992; 313():237-47. PubMed ID: 1332440
    [No Abstract]   [Full Text] [Related]  

  • 73. Isolation and properties of high molecular weight heparin.
    Radoff S; Danishefsky I
    Thromb Res; 1981 May; 22(3):353-65. PubMed ID: 7302903
    [No Abstract]   [Full Text] [Related]  

  • 74. Heparin: an old drug with a new paradigm.
    Jacques LB
    Science; 1979 Nov; 206(4418):528-33. PubMed ID: 386509
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Isotopic procedures in the structural analysis of heparin.
    Shively JE; Conrad HE
    Fed Proc; 1977 Jan; 36(1):28-31. PubMed ID: 12018
    [No Abstract]   [Full Text] [Related]  

  • 76. A new antithrombotic surface: development and in vitro and in vivo characteristics.
    Salzman EW; Austen WG; Lipps BJ; Merrill EW; Gilliland ER; Joison J
    Surgery; 1967 Jan; 61(1):1-10. PubMed ID: 6016662
    [No Abstract]   [Full Text] [Related]  

  • 77. Are low molecular weight heparins the same?
    Mousa SA
    Methods Mol Med; 2004; 93():49-59. PubMed ID: 14733327
    [No Abstract]   [Full Text] [Related]  

  • 78. Heparin: a drug of varying composition and effectiveness.
    Coon WW
    Clin Pharmacol Ther; 1978 Feb; 23(2):139-42. PubMed ID: 620473
    [No Abstract]   [Full Text] [Related]  

  • 79. Further characterization of dextran sulfate as a cofactor of protein C inhibitor.
    Kazama Y; Koide T; Sakuragawa N
    Thromb Res; 1989 Jun; 54(5):499-504. PubMed ID: 2475920
    [No Abstract]   [Full Text] [Related]  

  • 80. Physicochemical properties of heparin, and its interaction with Cu(II) and calcium in relation to anticoagulation.
    Stivala SS
    Fed Proc; 1977 Jan; 36(1):83-8. PubMed ID: 12019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.